|
1
|
Sun XJ, Rothenberg P, Kahn CR, et al:
Structure of the insulin receptor substrate IRS-1 defines a unique
signal transduction protein. Nature. 352:73–77. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yamauchi T, Ueki K, Tobe K, et al: Growth
hormone-induced tyrosine phosphorylation of EGF receptor as an
essential element leading to MAP kinase activation and gene
expression. Endocr J. 45(Suppl): S27–S31. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
White MF and Yenush L: The IRS-signaling
system: a network of docking proteins that mediate insulin and
cytokine action. Curr Top Microbiol Immunol. 228:179–208. 1998.
|
|
4
|
Smith-Hall J, Pons S, Patti ME, et al: The
60 kDa insulin receptor substrate functions like an IRS protein
(pp60IRS3) in adipose cells. Biochemistry. 36:8304–8310. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fantin VR, Sparling JD, Slot JW, Keller
SR, Lienhard GE and Lavan BE: Characterization of insulin receptor
substrate 4 in human embryonic kidney 293 cells. J Biol Chem.
273:10726–10732. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
White MF: IRS proteins and the common path
to diabetes. Am J Physiol Endocrinol Metab. 283:E413–E422. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Araki E, Lipes MA, Patti ME, et al:
Alternative pathway of insulin signalling in mice with targeted
disruption of the IRS-1 gene. Nature. 372:186–190. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Withers DJ, Gutierrez JS, Towery H, et al:
Disruption of IRS-2 causes type 2 diabetes in mice. Nature.
391:900–904. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Slattery ML, Samowitz W, Curtin K, et al:
Associations among IRS1, IRS2, IGF1, and IGFBP3 genetic
polymorphisms and colorectal cancer. Cancer Epidemiol Biomarkers
Prev. 13:1206–1214. 2004.PubMed/NCBI
|
|
10
|
Ding YC, McGuffog L, Healey S, et al: A
nonsynonymous polymorphism in IRS1 modifies risk of developing
breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2
mutation carriers. Cancer Epidemiol Biomarkers Prev. 21:1362–1370.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Esposito DL, Aru F, Lattanzio R, et al:
The insulin receptor substrate 1 (IRS1) in intestinal epithelial
differentiation and in colorectal cancer. PLoS One. 7:e361902012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bommer GT, Feng Y, Iura A, et al: IRS1
regulation by Wnt/beta-catenin signaling and varied contribution of
IRS1 to the neoplastic phenotype. J Biol Chem. 285:1928–1938. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ramocki NM, Wilkins HR, Magness ST, et al:
Insulin receptor substrate-1 deficiency promotes apoptosis in the
putative intestinal crypt stem cell region, limits
Apcmin/+tumors, and regulates Sox9. Endocrinology.
149:261–267. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Parsons DW, Wang TL, Samuels Y, et al:
Colorectal cancer: mutations in a signalling pathway. Nature.
436:7922005. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bishehsari F, Mahdavinia M, Malekzadeh R,
et al: Patterns of K-ras mutation in colorectal carcinomas from
Iran and Italy (a Gruppo Oncologico dell’Italia Meridionale study):
influence of microsatellite instability status and country of
origin. Ann Onco. 17 Suppl 7:vii91–vii96. 2006.PubMed/NCBI
|
|
16
|
Palmirotta R, Matera S, Curia MC, et al:
Correlations between phenotype and microsatellite instability in
HNPCC: implications for genetic testing. Fam Cancer. 3:117–121.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bottomley WE, Soos MA, Adams C, et al:
IRS2 variants and syndromes of severe insulin resistance.
Diabetologia. 52:1208–1211. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ng PC and Henikoff S: Predicting
deleterious amino acid substitutions. Genome Res. 11:863–874. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xi T, Jones IM and Mohrenweiser HW: Many
amino acid substitution variants identified in DNA repair genes
during human population screenings are predicted to impact protein
function. Genomics. 83:970–979. 2004. View Article : Google Scholar
|
|
20
|
Almind K, Bjørbaek C, Vestergaard H,
Hansen T, Echwald S and Pedersen O: Amino acid polymorphisms of
insulin receptor substrate-1 in non-insulin-dependent diabetes
mellitus. Lancet. 342:828–832. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Laakso M, Malkki M, Kekäläinen P, Kuusisto
J and Deeb SS: Insulin receptor substrate-1 variants in
non-insulin-dependent diabetes. J Clin Invest. 94:1141–1146. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Imai Y, Fusco A, Suzuki Y, et al: Variant
sequences of insulin receptor substrate-1 in patients with
noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab.
79:1655–1658. 1994.PubMed/NCBI
|
|
23
|
Ura S, Araki E, Kishikawa H, et al:
Molecular scanning of the insulin receptor substrate-1 (IRS-1) gene
in Japanese patients with NIDDM: identification of five novel
polymorphisms. Diabetologia. 39:600–608. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Esposito DL, Mammarella S, Ranieri A, et
al: Deletion of Gly723 in the insulin receptor substrate-1 of a
patient with noninsulin-dependent diabetes mellitus. Hum Mutat.
7:364–366. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Whitehead JP, Humphreys P, Krook A, et al:
Molecular scanning of the insulin receptor substrate 1 gene in
subjects with severe insulin resistance: detection and functional
analysis of a naturally occurring mutation in a YMXM motif.
Diabetes. 47:837–839. 1998. View Article : Google Scholar
|
|
26
|
Celi FS, Negri C, Tanner K, et al:
Molecular scanning for mutations in the insulin receptor
substrate-1 (IRS-1) gene in Mexican Americans with type 2 diabetes
mellitus. Diabetes Metab Res Rev. 16:370–377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Esposito DL, Li Y, Vanni C, et al: A novel
T608R missense mutation in insulin receptor substrate-1 identified
in a subject with type 2 diabetes impairs metabolic insulin
signaling. J Clin Endocrinol Metab. 88:1468–1475. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abecasis GR, Altshuler D, Auton A, et al:
A map of human genome variation from population-scale sequencing.
Nature. 467:1061–1073. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bernal D, Almind K, Yenush L, et al:
Insulin receptor substrate-2 amino acid polymorphisms are not
associated with random type 2 diabetes among Caucasians. Diabetes.
47:976–979. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Butte NF, Voruganti VS, Cole SA, et al:
Resequencing of IRS2 reveals rare variants for obesity but not
fasting glucose homeostasis in Hispanic children. Physiol Genomics.
43:1029–1037. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Heinen CD, Richardson D, White R and
Groden J: Microsatellite instability in colorectal adenocarcinoma
cell lines that have full-length adenomatous polyposis coli
protein. Cancer Res. 55:4797–4799. 1995.PubMed/NCBI
|
|
32
|
Giannini G, Rinaldi C, Ristori E, et al:
Mutations of an intronic repeat induce impaired MRE11 expression in
primary human cancer with microsatellite instability. Oncogene.
23:2640–2647. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
van der Heijden MS, Brody JR,
Elghalbzouri-Maghrani E, Zdzienicka MZ and Kern SE: Does
tumorigenesis select for or against mutations of the DNA
repair-associated genes BRCA2 and MRE11?: considerations from
somatic mutations in microsatellite unstable (MSI) gastrointestinal
cancers. BMC Genet. 7:32006.PubMed/NCBI
|
|
34
|
Chang Q, Li Y, White MF, Fletcher JA and
Xiao S: Constitutive activation of insulin receptor substrate 1 is
a frequent event in human tumors: therapeutic implications. Cancer
Res. 62:6035–6038. 2002.
|
|
35
|
Dearth RK, Cui X, Kim HJ, et al: Mammary
tumorigenesis and metastasis caused by overexpression of insulin
receptor substrate 1 (IRS-1) or IRS-2. Mol Cell Biol. 26:9302–9314.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dearth RK, Cui X, Kim HJ, Hadsell DL and
Lee AV: Oncogenic transformation by the signaling adaptor proteins
insulin receptor substrate (IRS)-1 and IRS-2. Cell Cycle.
6:705–713. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Houghton AM, Rzymkiewicz DM, Ji H, et al:
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung
tumor growth. Nat Med. 16:219–223. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Modica S, Morgano A, Salvatore L, et al:
Expression and localisation of insulin receptor substrate 2 in
normal intestine and colorectal tumours. Regulation by
intestine-specific transcription factor CDX2. Gut. 58:1250–1259.
2009. View Article : Google Scholar : PubMed/NCBI
|
